Datuk Seri Dr Tham Seng Kong
KUALA LUMPUR: Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.
It has an enterprise value of approximately US$1.6 billion.
